TINOVID

This brand name is authorized in Nigeria.

Active ingredients

The drug TINOVID contains one active pharmaceutical ingredient (API):

1	Ofloxacin UNII A4P49JAZ9H - OFLOXACIN
	Ofloxacin is a quinolone-carboxylic acid derivative with a wide range of antibacterial activity against both Gram-negative and Gram-positive organisms. The primary mode of action of the quinolones is the specific inhibition of bacterial DNA gyrase. This enzyme is required for DNA replication, transcription, repair and recombination.
	Read more about Ofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-2195	Tablet	Tinovid 400 mg Tablets TAB 400 mg	Each tablet contains: Ofloxacin USP 400 mg	07/05/2021
B4-2196	Tablet	Tinovid 200 mg Tablets TAB 200 mg	Each tablet contains: Ofloxacin USP 200 mg	07/05/2021
B4-7879	Ear/eye drops	TINOVID EYE/EAR DROPS SOL_DROPS 0.3% 1x10ml	TINOVID EYE/EAR DROPS OFLOXACIN Ofloxacin BP 0.3%w/v Hydroxypropyl Methylcellulose Bp 0.25Zo v Benzalkonium Chloride Solution Bp 0.02% v Aqueous Buffered Vehicle q.s. B4-7879 Drugs Imported Products 1x10ml Prescription Only Medicine (POM) 29/11/2022 SIMPEC PHARMACEUTICAL LIMITED, AKUSU LANE SAPELE DELTA 3676754 simpecpharm.naf@gmail.com SCOTT-EDIL PHARMACIA LIMITED, 56, E.P.I.P., PHASE 1, JHARMAJRI - 173,205, DISTT, SOLAN, INDIA., India	31/08/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA01	Ofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-2195, B4-2196, B4-7879